Ian Johnston Acquires 4,250 Shares of Amrize (NYSE:AMRZ) Stock

Amrize Ltd (NYSE:AMRZ) CFO Ian Johnston acquired 4,250 shares of the company’s stock in a transaction that occurred on Tuesday, March 10th. The shares were bought at an average cost of $58.94 per share, for a total transaction of $250,495.00. Following the acquisition, the chief financial officer directly owned 25,110 shares in the company, valued at $1,479,983.40. This represents a 20.37% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Amrize Stock Down 3.4%

AMRZ stock opened at $56.23 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $31.10 billion and a PE ratio of 22.86. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The stock has a 50-day simple moving average of $57.92 and a two-hundred day simple moving average of $53.64.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. Amrize’s revenue for the quarter was down .4% compared to the same quarter last year.

Trending Headlines about Amrize

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Significant insider buying from senior management (CEO disclosed a multi-million dollar purchase and other executives have added shares), which signals management conviction in the business. Insider Buying: Amrize CEO Acquires Stock
• Positive Sentiment: SEC filings show multiple recent purchases by the CTO, CFO and other insiders — cumulative insider accumulation increases alignment with shareholders. SEC Filing: Insider Transactions
• Positive Sentiment: Institutional buying and favorable analyst coverage (several raises/reaffirms and a “Moderate Buy” consensus) provide a constructive medium‑term backdrop. Brokerages Give AMRZ Moderate Buy
• Neutral Sentiment: Management emphasised an investment‑led growth strategy on the earnings call — positive for long term but may delay margin/near-term revenue improvements. Earnings Call Signals Investment‑Led Growth
• Negative Sentiment: Q4 revenue missed estimates (reported $2.84B vs. ~$2.95B expected) and was slightly down YoY — the top‑line miss is the main near‑term driver of weaker sentiment. MarketBeat: AMRZ Earnings/Revenue Details
• Negative Sentiment: Disclosure of a large increase in CEO compensation (reported jump year‑over‑year) could raise governance concerns for some investors. QuiverQuant: CEO 2025 Pay Revealed
• Negative Sentiment: Today’s pullback appears to be light‑volume and may reflect short‑term profit‑taking or cautious reaction to the revenue miss despite insider buys.

Analyst Ratings Changes

AMRZ has been the subject of several analyst reports. UBS Group raised their price target on shares of Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, January 8th. Berenberg Bank set a $70.00 price target on shares of Amrize in a report on Thursday, February 19th. Weiss Ratings downgraded Amrize from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, March 3rd. Oppenheimer reissued an “outperform” rating and set a $70.00 price objective (up from $64.00) on shares of Amrize in a research note on Thursday, February 19th. Finally, Vertical Research began coverage on Amrize in a research report on Tuesday, November 25th. They set a “hold” rating and a $54.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $64.14.

Institutional Trading of Amrize

Several institutional investors have recently added to or reduced their stakes in the business. Mengis Capital Management Inc. increased its holdings in shares of Amrize by 8.5% in the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock worth $311,000 after buying an additional 450 shares during the period. Groupama Asset Managment boosted its holdings in Amrize by 12.7% during the 4th quarter. Groupama Asset Managment now owns 28,889 shares of the company’s stock valued at $1,562,000 after acquiring an additional 3,254 shares during the period. Alpine Global Management LLC purchased a new stake in Amrize during the 4th quarter valued at about $1,893,000. MidFirst Bank bought a new position in Amrize during the 4th quarter worth approximately $187,000. Finally, River Road Asset Management LLC grew its position in Amrize by 26.1% during the 4th quarter. River Road Asset Management LLC now owns 2,883,536 shares of the company’s stock worth $155,942,000 after acquiring an additional 597,542 shares during the last quarter.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.